A5041805487- Pharmaceutical Practices and Patient Outcomes
- Blood Pressure and Hypertension Studies
- Dementia and Cognitive Impairment Research
- Medication Adherence and Compliance
- Hemodynamic Monitoring and Therapy
- Diabetes Management and Research
- Pharmacology and Obesity Treatment
- Chronic Kidney Disease and Diabetes
- Pharmacy and Medical Practices
- Cardiovascular Syncope and Autonomic Disorders
- Neurological Disorders and Treatments
- Heart Failure Treatment and Management
- Anesthesia and Sedative Agents
- Lipoproteins and Cardiovascular Health
- Antibiotic Use and Resistance
- Electroconvulsive Therapy Studies
- Health, Environment, Cognitive Aging
- Medical and Biological Sciences
- Nutritional Studies and Diet
- Heart Rate Variability and Autonomic Control
- Frailty in Older Adults
- Renal function and acid-base balance
- Diabetes Management and Education
- Hormonal Regulation and Hypertension
- Public Health in Brazil
Biomechanics Institute of Valencia
2024
Universitat de València
2024
Valencia Catholic University Saint Vincent Martyr
2023
Universidad Cardenal Herrera CEU
2021-2023
Laboratorios Farmaceúticos Rovi (Spain)
2021
GTx (United States)
2011-2015
Universidad de Granada
2012
American Pharmacists Association
2011
Cognitive impairment (CI) is known to be mediated by several risk and protective factors, many of which are potentially modifiable. Therefore, it important have up-to-date studies that address a standard assessment psychosocial, clinical lifestyle variables.We conducted cross-sectional observational study, with 24-month timeframe, estimate the relationship between factors associated dementia, according A-to-Z Dementia Knowledge. Participants were considered at CI if they tested positive for...
The usefulness of the community pharmacy blood pressure (BP) (CPBP) method in assessing effectiveness antihypertensive treatment has not been adequately studied. aim this study was to assess agreement between pharmacy, home, and physician office BP (POBP) measurement methods treated hypertensive patients.BP measured at (three visits), home (4 days) visits). Lin correlation-concordance coefficient (CCC) used evaluate quantitative agreement. qualitative establish patient's state evaluated...
The aim of this study was to measure the community pharmacy white-coat effect (CPWCE) in treated hypertensive patients and compare its magnitude with WCE physician's office (POWCE). This cross-sectional attempted cover population, more than 18 years age users a rural CP located Palmera (Valencia, Spain). Blood pressure (BP) measured at three different settings, according clinical guidelines: (three visits), PO home (4 consecutive days). defined as difference between average CPBP or BP BP:...
Dementia is a neurodegenerative disease with no cure that can begin up to 20 years before its diagnosis. A key priority in patients dementia the identification of early modifiable factors slow progression disease. Community pharmacies are suitable points for cognitive-impairment screening because their proximity patients. Therefore, continuous training professionals working directly impacts public health population. The main purpose this study was assess community pharmacists’ knowledge...
When home blood pressure (HBP) measurements are taken, the readings can be registered manually by patient and/or stored in device's memory. The instructions provided healthcare professionals would particularly relevant to guarantee reliability of manual (BP) figures and enhance clinical decision making. aim this study is assess agreement between HBP patients those memory after an educational session community pharmacists. Secondary data MEPAFAR Palmera studies have been used analysis. All...
Masked uncontrolled hypertension (MUCH) is associated with an increased cardiovascular risk. This condition frequent in the community pharmacy (i.e., CP-MUCH), but there no evidence on factors its presence that setting. The aim of this analysis was to explore these factors. A sample 98 treated hypertensive patients from MEPAFAR study, normal blood pressure (CPBP <135/85 mmHg), were analyzed. Blood (BP) also measured at home (4 days) and monitored for 24 h. CP-MUCH identified when either...
<title>Abstract</title> <bold>Purpose: </bold>Early screening for cognitive decline (CD) is crucial managing dementia risk factors and preventing disease progression. This study seeks to create a detailed profile patients who are candidates CD screening, with focus on identifying emerging deficits their underlying causes. <bold>Methods: </bold>We first performed systematic review of practices within community pharmacies. Following this, we analyzed data from 286 individuals were screened...
RESUMENObjetivo: detectar personas en riesgo alto o muy de padecer diabetes mellitus tipo 2 (DM2) alteraciones del metabolismo los hidratos carbono, derivación para posible diagnóstico al médico y realizar una intervención educativa.Métodos: estudio observacional transversal longitudinal prospectivo con educativa farmacias comunitarias situadas la provincia Valencia entre junio noviembre 2018.Se incluyeron usuarios las comunitarias, mayores 18 años, no diagnosticados DM2 que aceptaron...
Sendra-Lillo, J.1; Sabater-Hernández, D.2; Sendra-Ortolá, A.1; Martínez-Martínez, F.2 Author Information
Abstract Background Cognitive impairment (CI) is often diagnosed at moderate stages, with an estimated time for diagnosis of two years. However, the early CI allows control modifiable risk factors to prevent development dementia later ages. In addition, community pharmacy a close, accessible, and trustworthy health establishment where pharmacist participates in disease prevention, becoming suitable healthcare center facilitating detection cases Method A cross‐sectional observational study...